Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

kelly smith

- PMLiVE

Adaptive innovation

What your thymus can teach you about adapting to market changes

- PMLiVE

Archetypes: Rethinking go-to-market expectations to drive commercial success

In this white paper, our consultants analyze trends spanning global policy developments, rising inflation, and increasingly complex customer journeys, and reveal a new data-driven approach to archetyping that crystalizes the...

Avalere Health

Navigating patients step by step on their clinical trial journey

For clinical trial participants, navigating their way through a study can sometimes seem daunting and complicated. Without the right support, around 30% are likely to drop out [1], resulting in...

Innovative Trials

- PMLiVE

Innovative Trials responds to national recommendations to tackle UK clinical trial decline

Kate Shaw, Founder & CEO, comments on the Lord report of the Lord O’Shaughnessy review into commercial clinical trials in the UK.

Innovative Trials

- PMLiVE

AstraZeneca shares positive phase 3 results for Tagrisso in lung cancer

An estimated 2.2 million people worldwide are diagnosed with lung cancer each year

- PMLiVE

BMS presents positive four-year results for Opdivo combination in lung cancer

NSCLC is the most common type of lung cancer, representing up to 85% of diagnoses

- PMLiVE

Tuberculosis – why it remains a major global public health challenge

Innovative collaboration is required to address the major public health challenges around TB and expedite drug development

- PMLiVE

Whitepaper: Closing the gap with compelling healthcare communications

Want to learn how to close the distance between a person’s current health and their healthiest possible self?

Page & Page Health

- PMLiVE

Pfizer’s antibiotic combination shows promise in treating multi-drug resistant infections

AMR has been declared by WHO as one of the top ten threats to global health

- PMLiVE

Supporting the most vulnerable: why pharma should get behind the NHS’ healthcare equity campaign

By Oli Hudson

- PMLiVE

Healing the Healers

Because if we do not heal the healers, who is going to heal us?

Havas Lynx

The (inevitable) digital transformation of Medical Affairs

It’s not a question of ‘if,’ it’s a question of ‘when.’

Impetus Digital

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links